2 results
Approved WMOCompleted
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.
Not approvedWill not start
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.